Radiance Foundation, Inc. v. National Ass'n for the Advancement of Colored People

27 F. Supp. 3d 671, 2013 WL 8708579, 2013 U.S. Dist. LEXIS 188098
CourtDistrict Court, E.D. Virginia
DecidedDecember 11, 2013
DocketCivil Action No. 2:13cv53
StatusPublished
Cited by26 cases

This text of 27 F. Supp. 3d 671 (Radiance Foundation, Inc. v. National Ass'n for the Advancement of Colored People) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Radiance Foundation, Inc. v. National Ass'n for the Advancement of Colored People, 27 F. Supp. 3d 671, 2013 WL 8708579, 2013 U.S. Dist. LEXIS 188098 (E.D. Va. 2013).

Opinion

MEMORANDUM ORDER

RAYMOND A. JACKSON, District Judge.

Before the Court is Defendant National Association for the Advancement of Colored People’s (“Defendant”) Motion in Li-mine to Exclude Expert Report and Testimony of Tracy Tuten, Ph.D. (ECF No. 48) in the above-styled matter. Having carefully reviewed the parties’ pleadings, this matter is now ripe for judicial decision. For the reasons stated herein, Defendant’s Motion to Exclude is GRANTED IN PART and DENIED IN PART.

I. BACKGROUND AND PROCEDURAL HISTORY

Plaintiff The Radiance Foundation, Inc. is a non-profit organization founded by Plaintiff Ryan Bomberger that educates the public about social issues from a Christian perspective. Defendant National Association for the Advancement of Colored People provides educational and outreach services to African-Americans. After Defendant’s Senior Vice President publicly criticized Plaintiffs’ comparison of abortion to slavery as a part of their pro-life campaign, Bomberger wrote two news articles critiquing Defendant’s stance on abortion under the headline “National Association for the Abortion of Colored People.” These articles were posted on Plaintiffs’ websites toomanyaborted.com and thera-diancefoundation.org as well as a third-party website lifenews.com. Bomberger published a third article on lifenews.com that included a graphical depiction of Defendant’s Scales of Justice seal. Bomber-ger has used the NAACP acronym throughout his news articles and public speeches to refer to Defendant since June 2011.

On January 28, 2013, Defendant sent Plaintiffs a letter threatening to take legal action if Plaintiffs did not cease to use its federally registered trademarks “NAACP” and “National Association for the Advancement of Colored People” and its protected “Scales of Justice” seal and “Image Awards” phrase. On February 1, 2013, Plaintiffs filed a Complaint for Declaratory Relief, asserting that their use of Defendant’s marks does not constitute infringement and is protected speech under the First Amendment. Defendant filed counterclaims for trademark infringement and trademark dilution in violation of the Lan-ham Act and Virginia law. On November 6, 2013, Defendant filed the instant Motion in Limine to Exclude Expert Report and Testimony of Tracy Tuten, Ph.D.

II. LEGAL STANDARD

In Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), the United States Supreme Court’s (“Supreme Court”) established the standard for the [673]*673admissibility of expert testimony pursuant to Federal Rule of Evidence 702. Rule 702 provides that:

If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified* as an expert by knowledge, skill, experience, training, or education, may testify thereto in the form of an opinion or otherwise, if (1) the testimony is based upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.

Fed.R.Evid. 702; see also United States v. Wilson, 484 F.3d 267, 274-75 (4th Cir.2007). The Daubert decision rejected the prior rigid “general. acceptance” test of Frye v. United States, 293 F. 1013 (D.C.Cir.1923), and established a new twopart test for the admissibility of expert testimony. See Daubert, 509 U.S. at 589, 592-93, 113 S.Ct. 2786. Under Daubert, when a court is “[f]aced with a proffer of expert scientific testimony,” the court “must determine at the outset ... whether the expert is proposing to testify to (1) scientific knowledge that (2) will assist the trier of fact to understand or determine a fact in issue.” Id. at 592, 113 S.Ct. 2786; see also United States v. Moreland, 437 F.3d 424, 431 (4th Cir.2006). In Kumho Tire Co. v. Carmichael, 526 U.S. 137, 149, 119 S.Ct. 1167, 143 L.Ed.2d 238 (1999), the Supreme Court held that the Daubert test applies to all expert testimony falling under Rule 702.

“[U]nder the Rules the trial judge must ensure that any and all scientific testimony or evidence is not only relevant, but reliable.” Daubert, 509 U.S. at 597, 113 S.Ct. 2786. In determining whether the an expert possesses scientific knowledge so that the testimony is relevant and reliable, a court may consider five factors: (1) whether the particular scientific theory “can be (and has been) tested”; (2) whether the theory “has been subjected to peer review and publication”; (3) the “known or potential rate of error”; (4) the “existence and maintenance of standards controlling the technique’s operation”; and (5) whether the technique has achieved “general acceptance” in the relevant scientific or expert community. United States v. Crisp, 324 F.3d 261, 266 (4th Cir.2003) (citing Daubert, 509 U.S. at 593-94, 113 S.Ct. 2786). An additional factor to consider is whether the expert testimony was prepared solely for purposes of litigation, or whether it flowed naturally from the expert’s research or technical work. See Wehling v. Sandoz Pharms. Corp., 162 F.3d 1158 (4th Cir.1998) (“Another significant fact weighing against admitting the testimony is where, as here, the expert developed his opinions expressly for the purposes of testifying”); Daubert v. Merrell Dow Pharms., 43 F.3d 1311 (9th Cir.1995) (“Daubert II”) (“If the proffered expert testimony is not based on independent research, the party proffering it must come forward with other objective, verifiable evidence that the testimony is based on ‘scientifically valid principles’ ”). “[T]he trial judge must have considerable leeway in determining whether particular expert testimony is reliable.” Kumho Tire Co., 526 U.S. at 152, 119 S.Ct. 1167; see also Daubert, 509 U.S. at 595, 113 S.Ct. 2786 (noting that the decision whether to admit or exclude expert testimony for not being reliable “must be solely on principles and methodology, not on the conclusions that they generate.”); U.S. v. Dorsey, 45 F.3d 809, 814 (4th Cir.1995) (“a trial judge has a great deal of discretion in deciding whether to admit or exclude expert testimony.”). The proponent of expert testimony has the burden of establishing admissibility by a preponderance of the evidence. Cooper v. [674]*674Smith & Nephew, Inc., 259 F.3d 194, 199 (4th Cir.2001).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Blackjewel, L.L.C. v. United Bank
S.D. West Virginia, 2022
Kaur v. Boston Scientific Corporation
Superior Court of Delaware, 2022
Sgouros v. TransUnion Corp.
N.D. Illinois, 2022

Cite This Page — Counsel Stack

Bluebook (online)
27 F. Supp. 3d 671, 2013 WL 8708579, 2013 U.S. Dist. LEXIS 188098, Counsel Stack Legal Research, https://law.counselstack.com/opinion/radiance-foundation-inc-v-national-assn-for-the-advancement-of-colored-vaed-2013.